Cargando…
Scott Gottlieb’s Resignation as FDA Commissioner Is a Loss for Translational Medicine
Autor principal: | Mann, Douglas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488735/ https://www.ncbi.nlm.nih.gov/pubmed/31061931 http://dx.doi.org/10.1016/j.jacbts.2019.03.001 |
Ejemplares similares
-
Will COVID-19 Transform Translational Medicine?
por: Mann, Douglas L.
Publicado: (2020) -
Will the Precision Medicine Initiative Transform Cardiovascular Translational Research?
por: Mann, Douglas L., et al.
Publicado: (2016) -
Are Synthetic Data Derivatives the Future of Translational Medicine?
por: Foraker, Randi, et al.
Publicado: (2018) -
Will Artificial Intelligence Transform Translational Medicine: (Not So) Elementary, My Dear Watson
por: Mann, Douglas L.
Publicado: (2021) -
JACC: Basic to Translational Science and Preprint Servers: Accelerating the Pace of Translation
por: Mann, Douglas L.
Publicado: (2020)